Form 4: Biogen Director Eric K. Rowinsky Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Eric K. Rowinsky reports changes in beneficial ownership of Biogen Inc. stock, including the acquisition of 1,340 shares.
Summary
- On June 21, 2024, Eric K. Rowinsky, a director of Biogen Inc., reported changes in his beneficial ownership of the company's stock.
- Rowinsky acquired 1,340 shares of common stock.
- Following the transaction, Rowinsky beneficially owns 21,969 shares of Biogen Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The director's purchase could be seen as slightly positive, but it's not a strong indicator.
Positives
- The acquisition of shares by a director could be interpreted as a positive signal regarding the director's confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The change in beneficial ownership may be of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of transaction: acquisition of Biogen Inc. common stock. |
| 06/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.